Sorry, you need to enable JavaScript to visit this website.

Announcing the 2021 Pfizer Golden Ticket Program Winners

Octagon Therapeutics and Thymmune Therapeutics will each receive one year of bench space for one scientist at LabCentral, adjacent to Pfizer’s campus in Cambridge, Mass.

Pfizer has selected Thymmune Therapeutics (a cell therapy company working in immunology) and Octagon Therapeutics (working in autoimmune diseases and oncology) as the winners of the 2021 Pfizer Golden Ticket Program. Each Golden Ticket will provide these startups with a voucher for one year of prepaid rent for a reserved bench space for one scientist, including certain benefits of shared infrastructure and services.

“At Pfizer, we understand that the path to changing patients’ lives begins with early-stage research and the passionate work of scientists at the bench,” said Uwe Schoenbeck, Ph.D., Pfizer’s Senior Vice President and Chief Scientific Officer of Emerging Science & Innovation. “We are proud to reward innovative science through the Golden Ticket Program to support the next generation of potential breakthroughs – and to provide these deserving start-up companies with resources in the life sciences hub of Kendall Square. Our relationship with LabCentral is yet another way Pfizer seeks to enable external innovation, alongside our commitment to partnering and collaboration to push forward great science.”

“We are incredibly grateful for Pfizer’s congoing sponsorship of LabCentral and for their help in recognizing and supporting innovative life sciences companies conducting research in Massachusetts,” added Johannes Fruehauf, M.D., Ph.D., co-founder and president, LabCentral. “We are thrilled to continue to host Octagon Therapeutics and Thymmune Therapeutics, and we look forward to their ongoing pursuit of groundbreaking science alongside our community of entrepreneurs.”

This is Pfizer’s seventh year as a LabCentral platinum sponsor.

Golden Ticket winners and their use and receipt of a Golden Ticket are subject to all terms and conditions of the Golden Ticket Program. A listing of winners (including city of residence, date of receipt of the prize, and approximate value of the Golden Ticket) can be obtained by sending a self-addressed stamped envelope to the following address on or after November 15, 2021: Pfizer Inc., Attention: Site Affairs, 1 Portland St., Cambridge, MA 02139.

Science & Innovation
Pharma Peers Unite to Build DNA-Encoded Libraries

Finding tools and hits for targets in drug discovery can feel like hunting for four leaf clovers in a blizzard. And researcher Sylvie Sakata was close to giving up on one discovery tool, DNA-encoded libraries, when a new consortium started to fall into place.

Science & Innovation
What You Need to Know About a Promising Vaccine Candidate that May Stem the Growing Risk of Lyme Disease

Lyme disease is the most common vector-borne illness in the United States.1 The U.S. Centers for Disease Control and Prevention (CDC) says that state health departments reported over 63,000 cases in 2022.2 However, the CDC uses other methods to estimate that approximately 476,000 people in the U.S.

Science & Innovation
Mathematical Sandbox: How Quantitative Systems Pharmacology Steers Safer, Faster Drug Development

Fear and anxiety swirled when Dr. Cynthia J. Musante’s husband contracted COVID-19. He faced a greater risk of coming down with a severe case since he was already unwell.But all their worries vanished in just 24 hours.Dr.

Science & Innovation
From Math to Medicine: What Are Mathematical Models and How Do They Predict Pharmacology?

It sounds strange, but predicting how medications impact diseases and the body is a lot like forecasting the weather.To understand why, imagine opening a weather app on your smartphone to check the forecast for the upcoming weekend.

Science & Innovation
The Challenges of Defining, Understanding, and Addressing Long COVID

Years have passed since COVID-19 was declared a global pandemic.

Science & Innovation
The Science Behind Migraine and Headaches

If you've never had a migraine attack, it’s hard to imagine how a headache can knock someone out of commission.

Science & Innovation
Zinc Finger Transcription Factors: The On/Off Switch for Genes Inspired by Frogs

Have you ever noticed how effortlessly frogs cling to nearly every surface? Their sticky little fingers easily grab and hold onto just about anything they want.

Science & Innovation
How to Manage High Blood Pressure (With the Help of a Few Giraffes)

People have long adored giraffes for their friendly faces, their tall and somewhat strange stature and, of course, those impossibly long necks.

Purpose & Ideals
Why Medicine Flavor Matters in Drug Design, Especially for Kids

Medicines don’t work unless people take them. It sounds like an obvious statement. And yet, a large percentage of people—up to 50%1 even—struggle when it comes to swallowing medications.

Moving Beyond Clinical Trials: 4 Lessons From Real-World Data

Clinical trials continue to be the gold standard for studying the safety and efficacy of a new medicine.

How Finland’s Unique Genetic Heritage Is Being Used to Study the Links Between Genes and Diseases

The unique genetic heritage of the Finns — marked by repeated population bottlenecks and isolation from their neighbors in northern Europe — is helping scientists embark on a search for the complex links between genes and diseases.  Finland also has a robust network of biobanks, and the countr

Science & Innovation
Tackling Antibiotic Resistance

Pfizer and industry partners present roadmap for overcoming the threat that resistance poses. In an unprecedented collaboration, today, Pfizer and 13 industry partners released a comprehensive plan of action that lays out four key commitments we pledge to deliver by 2020 to reduce the rising incide